RxDoctor Payments Data

Harry Keefe, MD

Family Medicine · Pueblo, CONPI 1558326264

Payments from drug & device makers

$6,557in general payments, 2019–2025

Across 397 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$758
  • AbbVie$740
  • AstraZeneca$622
  • Amgen$468
  • Boehringer Ingelheim$356
  • Bayer$351
  • plus $3K from 42 others

What the payments were for

  • Food & beverage$6,557100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,557 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$64,801
Medicare patients
126
Services billed
701

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide127$143,745
EliquisApixaban77$75,717
JardianceEmpagliflozin70$69,821
MounjaroTirzepatide29$33,342
XareltoRivaroxaban24$24,705
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$21,462
QuliptaAtogepant12$12,869
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$9,054
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$6,490
Humalog Kwikpen U-100Insulin Lispro15$4,137
Losartan Potassium355$3,995
Incruse ElliptaUmeclidinium Bromide11$3,923
Levothyroxine Sodium296$3,889
Diclofenac Sodium37$3,790
Rosuvastatin Calcium342$3,658

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$758$143,745127 claims
PfizerEliquis$295$75,71777 claims
Boehringer IngelheimJardiance$356$69,82170 claims
Lilly USA, LLCMounjaro$303$33,34229 claims
GSKTrelegy Ellipta, Incruse Ellipta$26$25,38534 claims
Johnson & JohnsonXarelto$265$24,70524 claims
AbbVieQulipta$740$12,86912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Pueblo

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →